BIIB vs MEDP
Biogen vs Medpace — AI-powered side-by-side comparison
| Metric | BIIB | MEDP |
|---|---|---|
| AI Score | 61 | 62 |
| Price | $202.89 | $577.05 |
| P/E Ratio | 35.73× | 33.19× |
| ROE | 0.1% | 1.0% |
| Revenue Growth YoY | — | — |
| Gross Margin | 0.7% | 0.3% |
| Debt / Equity | 0.44× | 0.28× |
| Dividend Yield | 0.0% | 0.0% |
| RSI (14) | 48.3 | 58.0 |
| Beta | 0.158 | 1.151 |
| Expected Upside | +1.4% | +8.0% |
Want the full breakdown?
Committee votes, technicals, and trade plans for both companies.
BIIB Full Analysis
MEDP Full Analysis